Evidence map›Paper›PMID 11939591›Full record

ArticleJournal of neuropathology and experimental neurology2002

Altered distribution of cell cycle transcriptional regulators during Alzheimer disease.

Kelly L Jordan-Sciutto, Latha M Malaiyandi, Robert Bowser

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Discovery of cancer-preventive juices reactivating RB functions.Environmental health and preventive medicine · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kelly L Jordan-SciuttoDepartment of Pathology, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Latha M Malaiyandi
Robert Bowser
University of Pittsburgh · US

Funding

ROLE OF CELL CYCLE PROTEINS IN HIV ENCEPHALITISR01NS041202 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JORDAN-SCIUTTO, KELLY L · 2001 to 2015
$4.5M
NOVEL ANTIGEN IN DEVELOPING BRAIN AND ALZHEIMERS DISEASER29AG013208 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOWSER, ROBERT P · 1995 to 2000
$113k
NIA NIH HHS AG13208NINDS NIH HHS R01 NS041202
6 · The paper itself

Abstract

A number of mechanisms have been proposed to contribute to the selective neuronal cell loss observed during Alzheimer disease (AD). These include the formation and accumulation of amyloid-beta (Abeta)-containing plaques, neurofibrillary tangles (NFTs), and inflammatory processes mediated by astrocytes and microglia. Neuronal responses to such insults in AD brain include increased protein levels and immunoreactivity for kinases known to regulate cell cycle progression. One down-stream target of these cell cycle regulatory proteins, the Retinoblastoma susceptibility gene product (pRb), has been shown to exhibit altered expression patterns in AD. Furthermore, in vitro studies have implicated pRb and one of the transcription factors it regulates, E2F1, in Abeta-induced cell death. To further explore the role of these proteins in AD, we examined the distribution of the E2F1 transcription factor and the hyperphosphorylated form of pRb (ppRb), which is unable to bind and regulate E2F activity, in the cortex of patients with AD and in non-demented controls. We observed increased ppRb and E2FI immunoreactivity in AD brain, with ppRb predominately located in the nucleus and E2F1 in the cytoplasm. Although neither of these proteins significantly co-localized with NFTs, both ppRb and E2F1 were found in cells surrounding a subset of Abeta-containing plaques. These results support a role for G1 to S phase cell cycle regulators in AD.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseCell CycleCell Cycle ProteinsCerebral CortexDNA-Binding ProteinsE2F1 Transcription FactorE2F Transcription FactorsFemaleHumansImmunohistochemistryMaleMiddle AgedNeuronsPhosphorylationCell Cycle ProteinsDNA-Binding ProteinsE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsRetinoblastoma Proteintau ProteinsTranscription Factors

Identifiers

PMID11939591
PMCPMC3683585
OpenAlexW2338496726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.